Sofie Leyman
CRIG member
Lab technician-GMP unit Cell & Gene Therapy (UZ Gent)
Principal investigator: prof. Bart Vandekerckhove (MD, PhD)
Research focus
Enabling phase I trials with cell and gene therapy medicinal products
We have experience in the GMP-production of:
- Dendritic cell vaccines
- Lipid nanoparticles containing RNA
- Virus Specific T cells
Contact & links
- UZ Gent, entrance 71, route 724, C. Heymanslaan 10, 9000 Gent
- Sofie Leyman & the team of prof. Vandekerckhove provide GMP facility for cell- and gene therapy for phase I/II clinical trials
- Sofie Leyman is interested to receive invitations for presentations or talks